Belief BioMed to Collaborate with AskBio to Explore the Potential of New Gene Therapies

2024年09月25日

SHANGHAI, Sept. 25, 2024 /PRNewswire/ -- Belief BioMed Inc. (BBM), a biotech company focusing on innovative gene therapies, today announced a new strategic collaboration with Asklepios BioPharmaceutical, Inc. (AskBio)

China approves its first gene therapy for rare disease hemophilia B

Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A